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Evidcncc is prcscnted thaw incubation of rul liver cells with glucagon lends LO an increase in the phosphorylation oTspccif~c scrinc residues within 
insulin receptors, particularly in the prcscncu or insulin. Howtvcr, no changes in &her the tyrosinr phosphorylation of the rcccptors or the tyrosine 
kinasc aclivity towards a synthetic pcplidc substralc was detected. 
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I. INTRODUCTION 
One of the first events following insulin binding to the 
a-subunit of the receptor is the incrcascd autophospho- 
rylation of the/3-subunit on several tyrosine residues [I], 
which in turn stimulates the tyrosinc kinase activity of 
the receptor towards other substrates. It is widely accep- 
ted that the receptor tyrosine kinase activity plays an 
important role in the transmission of the effects of insu- 
lin to intracellular systems (for review, see [2]). On the 
other hand, the phosphorylation of the insulin receptor 
on serine or threonine residues may have an inhibitory 
effect on the kinase activity of the receptors. Evidence 
for such a mechanism has been obtained for phorbol 
esters apparently acting through protein kinase C [3.4]. 
There is also some indication that agents acting through 
cyclic AMP may have an inhibitory effect on the activity 
of the insulin receptor although the evidence is in part 
contradictory and certainly incomplete. It has been re- 
ported that cyclic AMP-dependent protein kinasc can 
phosphorylatc the insulin receptor in vitro, with a small 
concomitant inhibition of the tyrosine kinase activity of 
the receptor [5], but others have failed to find any effect 
of CAMP-dependent protein kinase [6] or ascribed the 
inhibition of the receptor tyrosine kinase to a mecha- 
nism which is independent of receptor phosphorylation 
[7]. In intact cells, there is evidence that increasing intra- 
cellular cyclic AMP concentrations may result in a dc- 
crease in the tyrosine kinase activity of the insulin rccep 
tors [S-lo]. Mowe\rer. in only one study [S] was the 
increase in cyclic AMP shown to be associated with an 
increase in the phosphoserine content of the receptor. 
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The effect of increasing cell cyclic AMP concentrations 
on the phosphorylation of individual sites within the 
insulin receptor has not been examined previously. 
Using a sensitive two-dimensional phosphopeptide 
mapping technique [I I]. we recently developed a proce- 
dure allowing the study of individual phosphorylation 
sites of insulin receptors in intact freshly isolated liver 
cells ([I21 and Fig. 1). Some marked differences were 
apparent between the pattern of phosphorylation sites 
in the fresh liver cells and those observed in a range of 
cultured cells including hepatoma cells [ 13,141 expres- 
sing high levels of the receptor. In particular, in liver 
cells: (1) there was no phosphorylation of the tyrosines 
close to the carboxyl terminus (1328 and 1334) although 
insulin caused a large increase in the phosphorylation 
in the three tyrosines in the kinase domain (I 158, I I62 
and 1163); (2) the phosphorylation of the threonine 
(1348) near to the carboxyl terminus was low in the 
presence and absence of insulin; (3) there was extensive 
phosphorylation of serines within the receptor in cells 
incubdtcd under basal conditions and only modest 
changes in serine phosphorylation with insulin [12]. 
In the present study, we have investigated the effects 
of increasing the concentration of cyclic AMP by gluca- 
gon on the phosphorylation of individual sites within 
the insulin receptors of intact fresh liver cells. 
2. MATERlALS AND METHODS 
2.2. P/tospltor~*fff dart of ittstrfiu iwqllrorr isi&% iitiurt lkr ceils 
This was pe~formcd as described in [ 151. Hcpatocylcs wcrc distribu- 
ted in four incubation vials (25 million/vial) and prcincubnted for 50 
min in 2 ml or Krcbs-Hen&it buffer containimt ~?, 10.2 mM. 1.5 
mCi/ml). then the cells were incubated for 15 minin tilt abscncc and 
prcscncc of glucagon (300 nM. Sigma, Poolc, England); where indi- 
cated insulin (200 nM1 was added for the last IO min orlhc incubation. 
The cells were then rapidly extracted a~ 2-VC in ice-cold HEPES 
buffer (100 mM. pH 7.(i) containing 2% Triton X-100.40 mM EDTA. 
20 mM NaF, 60 mM sodium pyrophosphatc. 4 mM bcnzamidinc. 2 
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mM NaJVO,. 2 mM phcnylmethylsulphonyl fluoride and 2pdrnl each 
of aprotinin, pcpstatin, antipuin and leupeptin. 
itwrliti recef~rors 
The purificiltion and mapping procedures have been fully detailed 
in [I I. 121. Fig. I provides a key to the various phosphopeptides deri- 
ved from the insulin nxeptor. The phosphopeptidcs were detected by 
radioautography; dcnsitometric scanning of the radioautographs was 
cxried out using a Chromoscan 3 (Joyce Loebl Ltd., UK) linked to 
u Hewlett-Packard series 300 computer. 
2.3. Mefr.srrwtrwnr of &J eso~rttorrs kihim ucrivir_v 0f rrcq~ro,:~ /iorft 
liwr crlls itmcfmmf it1 absence or presetwr qf’gltmgon cud ftmlin 
Liver cells wcrc prepared, incubated. extracted. and the rcccptors 
partially purilied by wheat*perm lectin Sepharose chromatography as 
for I?P labclling of the p-subunit. except that radioactive phosphate 
wds omitted. A sample of parlially purified rcccplor was removed and 
separated by SDS-PAGE for quantification of the amount of insulin 
receptor by Western blotting using chcmiluminesccnt detection 
[ I%lG]. Exogcnaus kinasc activity of the partially purified receptors 
was measured using a synthetic peptide RRDIFETDYFRK (designa- 
ted as the FYF peplide) corresponding to the kinasc domain of the 
human insulin receptor in which ryrosines I I55 and tic13 have been 
replaced by phenylaluninc (kindly provided by Dr. L. Ellis. University 
of Texas Southwestern Medical Center, Dallas). Equivalent amounts 
of partially purified insulin receptors were premincubatcd for 5 min at 
30°C in it final volume of SO ~1 containing 25 mM HEPES. I .5 mM 
EGTA. I mM NaJVOJ, I mM dithiothreitol, 12 mM MgCI, and 0.46 
mM of FY F peptide. The reaction was then started by adding 2 yCi 
of [y-“P]ATP (final concentnltion lOO,uM). The reaction was termi- 
nated by spotting a s;rmplc ofthc incubation mixture onto phosphocel- 
lulose PSI paper squares (Whaunan Labsalcs Ltd., Kent, UK). The 
papers were immersed in 0.5 litre of I50 mM H,PO, and washed 3 
times for I5 min with fresh I50 mM HJPO, and once in ethanol. dried 
and counted. Background radioactivity was determined for each incu- 
bation condition by performing an identical reaction in the absence 
of substrate peptidc. 
3. RESULTS 
The cells were incubated in the absence or presence 
of glucagon for 15 min and when appropriate insulin 
was added for the final 10 min. High concentrations of 
hormones were employed to ensure that maximal effects 
might be achieved. Fig. 2 shows a typical example of 
two-dimensional phosphopeptide maps of insulin recep- 
tors obtained under these conditions. Changes in the 
amounts of the various phosphopcptides in this experi- 
ment plus two others carried out under the same condi- 
tions are shown in Table 1. The table gives the effects 
of glucagon both in the absence and presence of insulin. 
In addition, the proportion of overall phosphorylation 
that can be ascribed to individual peptides are also given 
in order to correct for any differences in recovery that 
might occur during the preparation of the receptor and 
its phosphopeptides. The overall incorporation of ra- 
dioactivity into the@iubunit of the insulin receptor was 
1982470 (meanfSEM of 3 observations in the absence 
of hormones). This was increased to 4264t859 in the 
presence of insulin. Glucagon did not have a significant 
effect on the overall incorporation of radioactivity in 
either the absence or presence of insulin (Table I). 
The pattern of peptide phosphorylation in the ab- 
sence of hormones and with insulin alone were in excel- 
lent agreement with those obtained previously under 
essentially the same conditions [1.5]. Glucagon had no 
detectable effect on the phosphorylation of tyrosines 
within the insulin receptor both in the absence and pres- 
ence of insulin. It should be noted that the level of 
Table I 
Effect of glucagon on the phosphorylation of the insulin receptor in intact liver cells incubated in the presence and absence of insulin. Results arc 
taken from the experiment shown in Fig . 2 togcthcrwith two further independent cxpcrimcntscarried out in thcsamc way. Relative phosphorylation 
was deterrnincd by scanning of the radioautographs and is expressed as means ?SEM of three observations. A key to the phosphopcptidcs is given 
in Fig. I. *P<O.OS for the effect of RlucaRon versus unoromiate control. 
Peptidr 
meci 0r giucagOn (a) 
In absence In presence 
0r insulin 0r insulin 
Phosphorylation (as Ib of overall phosphorylntion) 
Control Glucegon Insulin Insulin + 
clucanon 
Kinasc domain 
Monophos. forms (Cl ) 
Bispbos. rorms (B2 + 93) 
Trisphos. forms (Al + A2) 







_ 14+7.8 Ilz5.0 8+1.9 1421.4 Il+l.s 
- 94230 5+2.6 321.2 21 no.5 l7J-I.9 
100-1-20 4-1-2.0 022.4 4522. I 431-3.3 
94220 202X.6 17+4.0 8l-tl.7 71&2.6* 
124229 274+42* 29k7.9 25+3 3 -_,_ 5f0.5 13-“2.2* 
71226 121+43 14r1.0 721.2” 420.7 320.5 
338?r84 408-t-243 12~11.3 3Ok5.6” 321.1 721.7 
132*32 179-r-61 SOkt8.G 83f4.0 19fl.7 2912.6* 
Overall 134241 l08f26 100 IO0 100 100 
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Fig. I. Key IO UIC phosphop~ptides dcrivcd from rat insulin rcccptors 
phosphorylatcd in intact liver cells. Taken I’rom [I I and 121. For USC 
orcomparison, wc huvc numbcrcd amino ucids in the insulin rcccptor 
xcording to the humor scyucncc dcscribcd in [2Oj. The amino acid 
sequence ol’ the P-subunit ol’ the rrtt rcccptor is very similar to the 
humun scrlucncc but thcrc is an insert or LWO umino acids in the 
a-chain [?I]. Autophosphorylation or the tyrosincs 1 158. 1162 and 
I 163 in ~hc kinasc domain cm give rise to a runlily ol’fivc phosphopcp- 
tides (gcneml scqucnce Asp-Ilc-Tyr-Glu-Thr-Asp-Tyr-Tyr-Arg-Lys) 
which urc mono-(Cl). bis-( 82 and B3) or tris-(A I and AZ) phosphory- 
lated and clcavcd by trypsin at Arg-I 155 and citlrcr Arg-I I64 (Cl. B3 
and AZ) or Lys-I It-15 (I32 and Al), [I I]. The other phosphopcptidcs 
are phosphoscrinc containing pcptidcswith thecxcrptionoTX3. which 
is L phosphothreoninc conmining pcptidc VLTLPR ([I?] uxl unpub- 
lishcd observations), 111 intsct liver cells. ~lte two tyrosincs From thr 
carboxyltcrminus (I325 and 1334) arc not phosphorylatcd and hcncc 
phosphopcptidc Bl is ubsrnt [ 121. 
phosphorylation of tyrosines in the kinase domain in 
the absence of insulin was too low both with and with- 
out glucagon for reliable percent changes in phospho- 
rylation to be calculated and hence these are not inclu- 
ded in Table I. On the other hand. glucagon did cause 
a 
increases in the phosphorylation of two phosphoserine 
containing peptides Xl and X5. IncorPoration into X5 
increased both in the absence and presence of insulin. 
However, the increases were variable in extent and only 
reached statistical significance using Students’s f-test 
when the results are expressed as percent of overall 
phosphorylation. X5 may not represent a single poly- 
peptide as it does not run as a discrete spot in the 
two-dimensional maps. Both X1 and X5 were found to 
contain only phosphoserinc when derived from recep 
tors of cells exposed to glucagon (Xl) or insulin plus 
glucagon (XI & X5). Glucagon stimulation of phospho- 
rylation of X I appeared only to incrcsse in the presence 
of insulin when there was a two- to three-fold enhance- 
ment. Overall, in the presence of insulin the effect of 
glucagon was to more than double the ratio of phospho- 
rylation of the two major phosphoserine containing 
peptides (XI and X5) to that of the major phosphotyro- 
sine containing peptides (Al,A2,52,B3 and Cl) from 
0. I3kO.02 to 0.27+0.03 (3 observations). Precise stoi- 
chiometrics cannot be calculated from the data given in 
Table 1: however, it cat1 be concluded that in the pres- 
ence of insulin and glucagon, the number of receptors 
phosphorylatcd on all three tyrosines in the kinase do- 
main (i.e. yielding peptidcsA1 and A2) is approximately 
the same as the number phosphorylated on peptide Xl 
(assuming this peptide only contains a single phospho- 
serine). 
In order to assess the extent to which the changes in 
phosphorylation of Xl and X5 with glucagon may be 
able to influence the tyrosine kinase activity of the insu- 
lin receptor, receptors were partially purified by wheat- 
b 
d 
Fig. 2. Two-dimensional maps of the phosphopcptides from liver cells. Artcr prcincubation, liver cells wet-c incubated I5 min either in the absence 
(panel A and C) or presence (panel B and D) of glucugon (300 nM). In puncls C and D. insulin (200 n M) was added for ~hc last IO min ofincubation. 
The position of an internal marker, DNP-lysinc (dotted oval) is shown. 
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germ lectin affinity chromatography from cells treated 
with hormones (under conditions used for peptidc map- 
ping) and the tyrosine kinase activity towards the FYF 
peptide determined. As can be seen from the results 
given in Fig. 3. kinase activity was increased more than 
ten-fold in the presence of insulin as expected from the 
increase in tyrosine phosphorylation within the kinase 
domain However, there was no evidence of any chan- 
ges following exposure of liver cells to gluca~on. 
4. DISCUSSKON 
This study represents the first analysis of the changes 
in the phosphorylation of the insulin receptor in freshly 
isolated cells treated with a hormone which increases 
cyclic AMP. Evidence has been obtained that exposure 
of hepatocytcs to &.~agon results in modest increases 
in the phosphorylation of the insulin receptor on serincs 
within two pcptides designated Xl and X5. In the case 
of XI, the increase was only evident in the presence of 
insulin and it is possible that insulin binding or the 
subsequent increase in tyrosine phosphorylation is a 
prerequisite before increased serine phosphorylation 
can occur within peptide Xl. Further studies are re- 
quired to establish the location of phosphopeptides Xl 
and X5 within theb-subunit of the insulin receptor and 
the protein serine kinases involved but CAMP-depend- 
ent protein kinase is unlikely to directly phosphorylate 
the insulin receptor [6.7]. Phospbopeptides Xl and X5 
are clearly distinct from the tryptic peptide containing 
serines 1305 and I306 which has been reported to be a 
major site of phosphorylation by the protein scrine ki- 
nase which copurifies with the insulin receptor [ 171. This 
phosphopeptide migrates further towards the cathode 
than X5 [16], and we barely detected any phosphoryla- 
tion of this peptide within intact cells exposed to insulin 
[I 2,14,lG and this study], and in any case, the major 
phosphoserine containing peptides are still evident in 
mutated human insulin receptors lacking 69 amino 
acids from the carboxyl terminus of the /&subunit and 
transfected into CHO cells [IS]. It is possible that the 
effects of glncagon may involve changes in the activity 
of phosphoserine protein phosphatase activity, for ex- 
ample through changes in the phosphorylation of inhib- 
itor I. 
Despite the increase in phosphoserine content pro- 
moted by glucagon, we were unable to detect any chan- 
ges in the extent of phosphorylation of insulin receptor 
tyrosines 1158,l I62 and I 163 or on exogenous tyrosine 
kinase activity subsequently assayed using a synthetic 
peptide substrate. These results contrast with those of 
Stadtmauer and Rosen [8] who obtained evidence that 
treatment of IM9 lymphoblasts with forskolin enhanced 
the basal phosphorylation of insulin receptors appar- 
ently mainly on serine residues and decreases the stimu- 
latory effect of insulin on tyrosine phosphorylation of 





















Fig. 3. EK?ct ofglucagon ~rc~tr~xnt on the exogenous tyrosinc kinasc 
activity of insulin receptors. Liver cells were incubiited us in Fig. 2, 
cxtrxtcd and tllc rexptors partially purified by chroniti\ography on 
wheat-germ leclin Scph;lrosc and assvycd for tyrosinu kinase activily 
lowards pcptide FYF (SL’L’ section 9). Equiv;llenl amounts ofreccpiors 
were used in each incubalion. Results arc cxprcsscd in pmol of phos- 
phnte incorporiitcd into the pcptidc/min/mg of proleins and rcprcsent 
the mean ?SEM of three scptir;ltc cxperimcn~s. 
sites involves were not identified. It is possible that fors- 
kolin treatment of IM9 cells alters the phosphorylation 
of residues in the receptor not phosphorylated in the 
intact liver cell such as the two tyrosines near to the 
carboxyl terminus or that the high level of scrine phos- 
phorylation of the liver receptor is already inhibitory 
under basal conditions. Certainly, 1M9 lymphoblasts 
are hardly typical insulin-sensitive cells and thus the 
effects of increasing cell cyclic AMP may not be re- 
presentative of those occurring in the cells of insulin- 
sensitive target tissues. Althou& the results of the pres- 
ent study suggest that increases in the serine phospho- 
rylation observed with glucagon do not affect the ty- 
rosine kinase activity of the insulin receptor, it is still 
possible that the increases alter some other important 
property of the receptor such as its ability to interact 
with other intracellular proteins that may be involved 
in insulin signallinl: such as the l85K phosphotyrosine 
containing protein [ 191, 
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